Health Care·Life Sciences Tools & Services·$6.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.20 | N/A | -0.04% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.20 | N/A | -0.04% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions impacting performance. They highlighted the importance of adapting strategies to navigate these challenges.
Management noted that they are facing challenges in the current market environment.
They emphasized the need for strategic adjustments moving forward.
Repligen Corp's earnings report indicates a slight miss on EPS, which contributed to a significant drop in stock price by 7.35%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. The defensive tone from management suggests they are aware of the challenges ahead and are focusing on strategic adjustments.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AGILENT TECHNOLOGIES
Feb 18, 2020